Grace B. Hatton

King's College London — United Kingdom

Medicine · Health Sciences

13h-index1.8kcitations22works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal motility and disorders(7), Clostridium difficile and Clostridium perfringens research(6), Gut microbiota and health(5), Additive Manufacturing and 3D Printing Technologies(4), 3D Printing in Biomedical Research(4)

Publications22 total

Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation
Science Advances·2025· 1 citedOpen Access
Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use
International Journal of Pharmaceutics·2025· 1 citedOpen Access
A water-based probiotic supplement shows antipathogenic activity against Clostridium perfringens, Klebsiella pneumoniae, and Listeria monocytogenes
SSRN Electronic Journal·2025Open Access
P52 Validation of an Algorithm to Identify Lines of Therapy Among Adult Patients With Endometrial and Ovarian Cancer in a Real-World Dataset
Value in Health·2023
Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards
Journal of Controlled Release·2022· 25 citedOpen Access
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
eJHaem·2022· 1 citedOpen Access
COVID-19 and clean air: an opportunity for radical change
The Lancet Planetary Health·2021Open Access
Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis
Current Hepatology Reports·2020· 6 citedOpen Access
Shaping the future: recent advances of 3D printing in drug delivery and healthcare
Expert Opinion on Drug Delivery·2019· 287 cited
P: 12 PROFIT: PROspective, Randomised Placebo-controlled Feasibility Trial of Faecal Microbiota Transplantation in Cirrhosis Interim Analysis
The American Journal of Gastroenterology·2019· 2 cited
Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption
Drug Discovery Today·2018· 58 citedOpen Access
Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Expert Review of Gastroenterology & Hepatology·2018· 28 citedOpen Access
Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?
Expert Review of Gastroenterology & Hepatology·2018· 15 cited
All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance
International Journal of Pharmaceutics·2018· 63 cited
Medical Applications of 3D Printing
AAPS advances in the pharmaceutical sciences series·2018· 11 cited
Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing
International Journal of Pharmaceutics·2015· 320 cited
Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans
Journal of Pharmaceutical Sciences·2015· 193 citedOpen Access
Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations
International Journal of Pharmaceutics·2015· 91 cited
A dynamic in vitro model to evaluate the intestinal release behaviour of modified-release corticosteroid products
Journal of Drug Delivery Science and Technology·2015· 25 cited
3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets
European Journal of Pharmaceutics and Biopharmaceutics·2014· 550 cited
page 1 of 2Next →

Frequent Co-authors

Abdul W. Basit(11), Álvaro Goyanes(5), Simon Gaisford(5), Christine M. Madla(4), Debbie L. Shawcross(4), Simon Goldenberg(3), Asma B. M. Buanz(2), Hamid A. Merchant(2), Felipe Varum(2), Sarit C. Rabbie(2), Nur Masirah M. Zain(2), Daniëlle ter Linden(2), Andrew Lilley(2), Paul G. Royall(2), Sophia Tsoka(2), Kenneth D. Bruce(2), A. James Mason(2), Elizabeth Allen(2), Ben Forbes(2), Hanah Chang(1)